Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-29 Sale | 2024-01-30 7:07 pm | Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner | 8,637 | $2.12 | $18,310 | 8,801,823 (Indirect) | View |
2024-01-24 Sale | 2024-01-26 7:19 pm | Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner | 43,776 | $2.2121 | $96,835 | 8,810,460 (Indirect) | View |
2024-01-19 Sale | 2024-01-23 8:02 pm | Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner | 27,587 | $2.1224 | $58,551 | 8,854,236 (Indirect) | View |
2023-12-14 Purchase | 2023-12-18 3:26 pm | Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer | 100,000 | $1.2699 | $126,989 | 328,122 (Direct) | View |
2023-11-17 Sale | 2023-11-21 7:27 pm | Oncology Institute Inc. | TOI | Hively Brad Director | 25,000 | $2.24 | $56,000 | 2,442,496 (Direct) | View |
2023-11-13 Sale | 2023-11-15 6:49 pm | Oncology Institute Inc. | TOI | Hively Brad Director | 47,000 | $2.523 | $118,581 | 2,467,496 (Direct) | View |
2023-03-17 Purchase | 2023-03-21 9:01 pm | Oncology Institute Inc. | TOI | BARASCH RICHARD A Director | 50,000 | $0.54991 | $27,495 | 257,201 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-12 Other | 2024-11-18 6:54 pm | N/A N/A | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 28,398 | $0 | 104,368 (Direct) | View |
2024-11-12 Other | 2024-11-18 6:52 pm | N/A N/A | Oncology Institute Inc. | TOI | Pacala Mark L Director | 50,620 | $0 | 135,029 (Direct) | View |
2024-11-12 Other | 2024-11-18 6:50 pm | N/A N/A | Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer | 195,236 | $0 | 916,947 (Direct) | View |
Ownership | 2024-09-30 4:30 pm | N/A N/A | Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer | 0 | $0 | 121,388 (Direct) | View |
2024-08-16 Other | 2024-08-20 06:15 am | N/A N/A | Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner | 16,333,241 | $0 | 16,585,867 (Indirect) | View |
2024-06-17 Disposition | 2024-06-20 4:17 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 18,121 | $0.4578 | 676,203 (Direct) | View |
2024-05-22 Disposition | 2024-05-23 7:22 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 19,526 | $0.5753 | 694,324 (Direct) | View |
2024-05-21 Disposition | 2024-05-23 6:33 pm | N/A N/A | Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer | 11,173 | $0.5972 | 1,413,240 (Direct) | View |
2024-05-21 Option Award | 2024-05-23 6:33 pm | N/A 2034-05-21 | Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer | 694,810 | $0 | 1,413,240 (Direct) | View |
2024-05-21 Option Award | 2024-05-23 6:33 pm | N/A 2034-05-21 | Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer | 530,107 | $0 | 853,579 (Direct) | View |
2024-05-21 Option Award | 2024-05-23 6:33 pm | N/A 2034-05-21 | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 61,355 | $0 | 148,193 (Direct) | View |
2024-05-21 Option Award | 2024-05-23 6:33 pm | N/A 2034-05-21 | Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer | 245,419 | $0 | 257,759 (Direct) | View |
2023-12-28 Other | 2024-01-02 5:01 pm | N/A N/A | Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner | 8,561,048 | $0 | 17,442,871 (Indirect) | View |
2023-12-26 Option Award | 2023-12-28 5:58 pm | N/A N/A | Oncology Institute Inc. | TOI | BARASCH RICHARD A Director | 80,000 | $0 | 337,201 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 5:46 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 42,652 | $0 | 713,850 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 5:38 pm | N/A N/A | Oncology Institute Inc. | TOI | Johnson Karen Marie Director | 52,000 | $0 | 115,185 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 5:27 pm | N/A N/A | Oncology Institute Inc. | TOI | Kaushal Mohit Director | 53,326 | $0 | 121,253 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 5:16 pm | N/A N/A | Oncology Institute Inc. | TOI | Ling Gabriel Director | 40,000 | $0 | 69,057 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 5:06 pm | N/A N/A | Oncology Institute Inc. | TOI | McGeorge Anne Director | 56,000 | $0 | 127,346 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 4:58 pm | N/A N/A | Oncology Institute Inc. | TOI | O'Meara Maeve Director | 50,000 | $0 | 109,104 (Direct) | View |
2023-12-26 Option Award | 2023-12-28 4:09 pm | N/A N/A | Oncology Institute Inc. | TOI | Pacala Mark L Director | 46,630 | $0 | 135,029 (Direct) | View |
2023-11-30 Option Award | 2023-12-04 7:42 pm | N/A 2033-11-30 | Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer | 43,189 | $0 | 43,189 (Direct) | View |
2023-11-21 Disposition | 2023-11-22 9:01 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 25,867 | $2.193 | 671,198 (Direct) | View |
2023-11-21 Disposition | 2023-11-22 8:47 pm | N/A N/A | Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer | 4,322 | $2.193 | 729,603 (Direct) | View |
2023-11-21 Disposition | 2023-11-22 8:37 pm | N/A N/A | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 1,530 | $2.193 | 86,838 (Direct) | View |
2023-11-17 Exercise | 2023-11-21 7:27 pm | N/A 2029-12-02 | Oncology Institute Inc. | TOI | Hively Brad Director | 25,000 | $0 | 2,442,496 (Direct) | View |
2023-11-17 Exercise | 2023-11-21 7:27 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 25,000 | $0.85 | 2,442,496 (Direct) | View |
2023-11-14 Disposition | 2023-11-16 4:40 pm | N/A N/A | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 1,860 | $2.385 | 88,368 (Direct) | View |
2023-11-14 Disposition | 2023-11-16 4:40 pm | N/A N/A | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 238 | $2.386 | 88,368 (Direct) | View |
2023-11-14 Disposition | 2023-11-16 3:56 pm | N/A N/A | Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer | 4,604 | $2.385 | 733,925 (Direct) | View |
2023-11-14 Disposition | 2023-11-15 6:49 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 27,117 | $2.388 | 2,467,496 (Direct) | View |
2023-11-13 Exercise | 2023-11-15 6:49 pm | N/A 2029-12-02 | Oncology Institute Inc. | TOI | Hively Brad Director | 47,000 | $0 | 2,467,496 (Direct) | View |
2023-11-13 Exercise | 2023-11-15 6:49 pm | N/A N/A | Oncology Institute Inc. | TOI | Hively Brad Director | 47,000 | $0.85 | 2,467,496 (Direct) | View |
2023-05-23 Disposition | 2023-05-24 8:43 pm | N/A N/A | Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer | 3,442 | $0.428 | 223,472 (Direct) | View |
2023-03-17 Option Award | 2023-03-21 9:06 pm | N/A N/A | Oncology Institute Inc. | TOI | Kaushal Mohit Director | 19,685 | $0 | 42,393 (Direct) | View |
2023-03-17 Option Award | 2023-03-21 9:04 pm | N/A 2033-03-17 | Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer | 116,266 | $0 | 173,513 (Direct) | View |
2023-03-17 Option Award | 2023-03-21 9:00 pm | N/A 2033-03-17 | Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer | 616,668 | $0 | 667,391 (Direct) | View |
2023-03-17 Option Award | 2023-03-21 8:56 pm | N/A 2033-03-17 | Oncology Institute Inc. | TOI | Miller Matthew P Chief Operating Officer | 236,836 | $0 | 412,161 (Direct) | View |